EDGAR Filing Documents for 0001144204-16-102650

Form 8-K - Current report:

SEC Accession No. 0001144204-16-102650

Filing Date

2016-05-16

Accepted

2016-05-16 16:29:00

Documents

Period of Report

2016-05-15

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	v440050_8k.htm	8-K	27936
2	EXHIBIT 4.1	v440050_ex4-1.htm	EX-4.1	91679
3	EXHIBIT 5.1	v440050_ex5-1.htm	EX-5.1	9101
4	EXHIBIT 10.1	v440050_ex10-1.htm	EX-10.1	308555
5	EXHIBIT 10.2	v440050_ex10-2.htm	EX-10.2	47834
6	EXHIBIT 99.1	v440050_ex99-1.htm	EX-99.1	12026
7	GRAPHIC	tex10-2logo.jpg	GRAPHIC	17393
8	GRAPHIC	tex99-1logo.jpg	GRAPHIC	8002
	Complete submission text file	0001144204-16-102650.txt		533807

Mailing Address 84 OCTOBER HILL ROAD SUITE 11 HOLLISTON MA 01746

Business Address 84 OCTOBER HILL ROAD SUITE 11 HOLLISTON MA 01746 (774) 233-7300

Biostage, Inc. (Filer) CIK: 0001563665 (see all company filings)